Sigma and Rna Polymerase an on-again Off-again Relationship

Summary

Contour

Financials

Events

Ownership

Options

Competitors

Symbol	Concluding	Alter
RNA	20.01	1.54 (8.34%)
CHRS	12.85	-0.06 (-0.46%)
ORGO	vii.89	0.27 (three.54%)
MOR	vii.00	0.22 (3.24%)
CERS	five.67	0.xviii (3.28%)

Visitor Info

Industry	Biotechnology
Sector	Health Engineering
Employees	125
CEO	Ms. Sarah Boyce

Avidity Biosciences, Inc. engages in the evolution of a new class of oligonucleotide-based therapies called Antibiotic Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in club to admission previously undruggable tissue and prison cell types and more finer target underlying genetic drivers of diseases. The company was founded past Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Argument Summary

as of 4:00 ET PM 03/31/2022

Total Assets (MRQ)	427.half dozen M
Total Liabilities (MRQ)	46.2 Chiliad
Shareholders' Equity (MRQ)	381.iv Thousand
Full Revenue (Annual)	1.9 G
Net Income (Annual)	-38.five M

Earnings And Estimates

as of 4:00 ET PM 03/31/2022

Current Qtr EPS Estimate	-0.80
Current FY EPS Estimate	-3.54
Long Term EPS Growth Estimate	n/a
Next Expected Earnings Engagement	v/11/2022

RNA vs S&P 500

every bit of 03/31/2022

	Relative To S&P 500	RNA
four Weeks	n/a	northward/a
12 Weeks	n/a	due north/a
YTD	n/a	due north/a

Earnings Surprises

as of 4:00 ET PM 03/31/2022

Fiscal Quarter	Estimate	Actual	Surprise
12/2021	-0.70	-0.82	+17.56%
09/2021	-0.68	-0.68	+0.44%
06/2021	-0.71	-0.70	-ane.75%
03/2021	-0.56	-0.64	+14.97%
12/2020	-0.34	-0.43	+25.55%
09/2020	-0.37	-0.31	-15.07%
06/2020	-0.36	-1.23	+240.08%

Financial Strength

equally of four:00 ET PM 03/31/2022

Pre-Tax Margin	-two.00
Cyberspace Margin	-173.87
Operating Margin	-2.00
Return On Disinterestedness	-34.32
Return On Assets	-thirty.99
Inventory Turnover (TTM)	0.00
Sales Growth (MRQ)	n/a

Ratios

as of 4:00 PM ET 03/31/2022

Price/Earnings (TTM)	n/a
Price/Book (MRQ)	ii.51
Price/Cash Flow (TTM)	0.00
Book Value (MRQ)	seven.99
Quick Ratio (MRQ)	13.86
Electric current Ratio (MRQ)	13.86
Total Debt/Equity (MRQ)	0.03

Short Interest

as of 4:00 PM ET 04/01/2022

	% Brusque - 0.00%
	% Remaining Bladder - 100.00%

	Current	Last Calendar month
Short Interest Appointment	n/a	n/a
Short Interest Shares	0	0
Short Interest Ratio	0.0	0.0

Balance Sheet
Income Argument
Greenbacks Catamenia

One thousand Y M Y

Total Assets 0,0.00 0,0.00

Total Liabilities 0,0.00 0,0.00

Total Equity 0,0.00 0,0.00

M Y Chiliad Y

Full Acquirement 0,0.00 0,0.00

EBT Exc.
Unusual Items 0,0.00 0,0.00

Net Income 0,0.00 0,0.00

One thousand Y M Y

Greenbacks from
Operations 0,0.00 0,0.00

Cash from
Activities 0,0.00 0,0.00

Cash from

Fin. Activities 0,0.00 0,0.00

Balance Canvass
Income Statement
Cash Menstruum

Select Menses

Full Avails	Total LIABILITIES	TOTAL EQUITY

Residual Canvas

	M Y
Avails
Cash And Equivalents	0,0.00
Receivables	0,0.00
Inventories	0,0.00
Other Electric current Avails	0,0.00
Full Current Assets	0,0.00
Holding, Plant & Equipment, Gross	0,0.00
Accumulated Depreciation & Depletion	0,0.00
Property, Establish & Equipment, Net	0,0.00
Intangibles	0,0.00
Other Not-Current Assets	0,0.00
Total Non-Current Assets	0,0.00
TOTAL ASSETS	0,0.00
Liabilities & Shareholder Equity
Accounts Payable	0,0.00
Short Term Debt	0,0.00
Total Current Liabilities	0,0.00
Long Term Debt	0,0.00
Deferred Income Taxes	0,0.00
Other Non-Electric current Liabilities	0,0.00
Minority Interest	0,0.00
Full Non-Current Liabilities	0,0.00
Preferred Stock Disinterestedness	0,0.00
Common Stock Equity	0,0.00
Mutual Par	0,0.00
Additional Paid In Capital	0,0.00
Cumulative Translation Adjustment	0,0.00
Retained Earnings	0,0.00
Treasury Stock	0,0.00
Other Equity Adjustments	0,0.00
Full Capitalization	0,0.00
Full EQUITY	0,0.00
Full LIABILITIES & STOCK EQUITY	0,0.00
Total Mutual Shares Outstanding	0,0.00
Preferred Shares	0,0.00
Treasury Shares	0,0.00
Basic Weighted Shares Outstanding	0,0.00
Diluted Weighted Shares Outstanding	0,0.00
Number Of Employees	0,0.00
Number Of Part-Time Employees	0,0.00

Select Menses

TOTAL REVENUES	EBT Excluding Unusual Items	NET INCOME

Income Statement

	1000 Y
Sales	0,0.00
Cost Of Sales	0,0.00
Gross Operating Profit	0,0.00
Selling, General, And Administrative Expenses	0,0.00
Inquiry & Development	0,0.00
Operating Income Earlier D & A (EBITDA)	0,0.00
Depreciation & Amortization	0,0.00
Interest Income	0,0.00
Other Income - Internet	0,0.00
Special Income / Charges	0,0.00
Full Income Before Interest Expenses (EBIT)	0,0.00
Interest Expense	0,0.00
Pre-Taxation Income	0,0.00
Income Taxes	0,0.00
Minority Interest	0,0.00
Cyberspace Income From Continuing Operations	0,0.00
Cyberspace Income From Discontinued Operations	0,0.00
Net Income From Total Operations	0,0.00
Extraordinary Income/Losses	0,0.00
Income From Cum. Effect Of Acct. Modify	0,0.00
Income From Tax Loss Carryforward	0,0.00
Other Gains / Losses	0,0.00
Total Net Income	0,0.00
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Preferred Dividends	0,0.00
Net Income Bachelor To Common	0,0.00
Bones EPS From Continuing Ops.	0,0.00
Basic EPS From Discontinued Ops.	0,0.00
Bones EPS From Total Operations	0,0.00
Bones EPS From Boggling Inc.	0,0.00
Basic EPS From Cum Consequence Of Accounting Change	0,0.00
Basic EPS From Tax Loss Carryf'd.	0,0.00
Basic EPS From Other Gains (Losses)	0,0.00
Basic EPS, Total	0,0.00
Basic Normalized Internet Income/Share	0,0.00
EPS From Continuing Ops.	0,0.00
EPS From Discontinued Ops	0,0.00
EPS From Total Ops.	0,0.00
EPS From Extraord. Inc.	0,0.00
EPS From Cum Effect of Accounting Alter	0,0.00
EPS From Revenue enhancement Loss Carfd.	0,0.00
EPS From Other Gains (L)	0,0.00
EPS, Total	0,0.00
Diluted Normalized Cyberspace Inc/Shr (Cyberspace Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Dividends Paid Per Share	0,0.00

Select Period

Greenbacks FROM OPERATIONS	Cash FROM INVESTING ACTIVITIES	Greenbacks FROM FINANCING ACTIVITIES

Cash Flow Argument

	M Y
Greenbacks Menstruum From Operating Activities
Net Income (Loss)	0,0.00
Operating Gains/Losses	0,0.00
Gross Operating Profit	0,0.00
(Increase) Decrease In Receivables	0,0.00
(Increment) Decrease In Inventories	0,0.00
(Increase) Decrease In Other Current Assets	0,0.00
(Decrease) Increment In Other Current Liabilities	0,0.00
(Increment) Subtract In Other Working Capital	0,0.00
Other Not-Cash Items	0,0.00
Net Greenbacks From Continuing Operations	0,0.00
Net Cash From Discontinued Operations	0,0.00
Greenbacks Provided By Investing Activities
Net Greenbacks From Full Operating Activities	0,0.00
Auction Of Property, Plant & Equipment	0,0.00
Cash Used For Investing Activities
Auction Of Short-Term Investments	0,0.00
Purchases Of Property, Plant & Equipment	0,0.00
Acquisitions	0,0.00
Purchases Of Short-Term Investments	0,0.00
Other Cash From Investing Activities	0,0.00
Cash Provided past Financing Activities
Net Cash From Investing Activities	0,0.00
Issuance Of Debt	0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock	0,0.00
Repayment Of Long-Term Debt	0,0.00
Repurchase Of Capital Stock	0,0.00
Payment Of Cash Dividends	0,0.00
Other Financing Charges, Internet	0,0.00
Cyberspace Cash From Financing Activities	0,0.00
Effect Of Exchange Rate Changes	0,0.00
Net Change In Cash & Cash Equivalents	0,0.00

Earnings Estimates

equally of four:00 ET PM 03/31/2022

Quarterly
Almanac

	Current Qtr (03/2022)	Next Qtr (06/2022)
Consensus Estimate	$-0.lxxx	$-0.85
# of Estimates	v	v
Loftier Estimate	$-0.60	$-0.66
Depression Estimate	$-1.00	$-1.09
Year Ago EPS	$-0.64	$-0.70
Year Over Yr Growth Approximate	25.65%	21.42%

	Current Yr (12/2022)	Adjacent Year (12/2023)
Consensus Guess	$-3.54	$-four.07
# of Estimates	5	5
High Estimate	$-2.69	$-3.eleven
Depression Guess	$-4.sixty	$-5.21
Year Ago EPS	$-two.85	$-iii.54
Year Over Year Growth Estimate	24.09%	15.12%

	Current Qtr (03/2022)	Next Qtr (06/2022)	Current Year (12/2022)	Next Yr (12/2023)
Consensus Estimate	$-0.80	$-0.85	$-3.54	$-4.07
# of Estimates	v	v	five	v
High Estimate	$-0.60	$-0.66	$-2.69	$-3.11
Low Estimate	$-1.00	$-1.09	$-4.60	$-5.21
Year Ago EPS	$-0.64	$-0.lxx	$-two.85	$-3.54
Year Over Year Growth Estimate	25.65%	21.42%	24.09%	xv.12%